A Study to Review Magnetic Resonance Imaging in Patients with Epilepsy


About this study

The primary purpose of this study is to compare the diagnostic utility of 7T MRI versus 3T MRI in the detection of subtle epileptogenic lesions in the brain.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with epilepsy having previously undergone brain imaging using a 7T MRI scanner as part of their diagnostic evaluation.

Exclusion Criteria: 

  • Patients in which a prior 3T brain MRI was diagnostic for an epileptogenic lesion at the time of initial interpretation.
  • Prospective patients who do not sign and return the HIPAA use consent form.
  • Patients with large, confounding cerebral pathologies such as large infarcts or brain tumors.
  • Patients with poor 7T image quality due head motion or other technical issues

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kirk Welker, M.D.

Open for enrollment

Contact information:

Sherry Klingerman CCRP



More information


Publications are currently not available